Drug Database
Back to search

Belgium· BE-AMP-SAM460711-00

Neuraceq 300 MBq/ml

A florbetaben (18f) product containing florbetaben (f-18), registered in Belgium by Lantheus Germany. The same ATC class is registered in 11 of our 19 countries.

ATC V09AX06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNeuraceq 300 MBq/mlATCV09AX06REGISTER NO.BE-AMP-SAM460711-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about florbetaben (f-18)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Florbetaben (18f) is registered in 11 of 19 countries.

Countries holding a registration under ATC V09AX06 (florbetaben (18f)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search florbetaben (18f) products by name

Florbetaben (18f) · ATC V09AX06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Florbetaben (F-18)
Manufacturer
Lantheus Germany
Country
Belgium (BE)
ATC code
V09AX06
ATC class
Florbetaben (18F)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4951083

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Florbetaben (18f) in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All florbetaben (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Neuraceq
  • Liechtenstein · Neuraceq
  • Norway · Neuraceq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b57d356f-0f53-4e53-a808-1e7ad97136ee
GET /v1/drugs/b57d356f-0f53-4e53-a808-1e7ad97136ee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Neuraceq 300 MBq/ml",
  "name_fr": "Neuraceq 300 MBq/ml",
  "name_nl": "Neuraceq 300 MBq/ml",
  "amp_code": "SAM460711-00",
  "strengths": [
    "300.0000",
    "300.0000",
    "300.0000",
    "1.2000"
  ],
  "pack_count": 1,
  "substances": [
    "Florbetaben (F-18)",
    "Ethanol",
    "Sodium Ascorbate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Florbetaben (18F)",
  "authorisation_numbers": [
    "EU/1/13/906/001"
  ]
}
API referenceMCP serverPlans

See everything about florbetaben (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console